118 related articles for article (PubMed ID: 6168849)
1. Mechanism of the antihypertensive action of DL-alpha-monofluoromethyldopa: implications for the role of the sympathetic nervous system in maintenance of elevated blood pressure in spontaneously hypertensive rats.
Fozard JR; Möhring J; Palfreyman MG; Koch-Weser J
J Cardiovasc Pharmacol; 1981; 3(5):1038-49. PubMed ID: 6168849
[TBL] [Abstract][Full Text] [Related]
2. Depression of sympathetic nervous function by DL-alpha-monofluoromethyldopa, an enzyme-activated, irreversible inhibitor of L-aromatic amino acid decarboxylase.
Fozard JR; Spedding M; Palfreyman MG; Wagner J; Möhring J; Koch-Weser J
J Cardiovasc Pharmacol; 1980; 2(3):229-45. PubMed ID: 6156322
[TBL] [Abstract][Full Text] [Related]
3. Blood pressure lowering effects of N,N-di-n-propyl-dopamine in rats: evidence for stimulation of peripheral dopamine receptors leading to inhibition of sympathetic vascular tone.
Cavero I; Lefèvre-Borg F; Gomeni R
J Pharmacol Exp Ther; 1981 Aug; 218(2):515-24. PubMed ID: 7252851
[TBL] [Abstract][Full Text] [Related]
4. [The relationship between regional sympathetic activity and the onset of arterial hypertension in spontaneously hypertensive rats].
Cabassi A; Vinci S; Calzolari M; Bruschi G; Cavatorta A; Borghetti A
Cardiologia; 1997 Apr; 42(4):393-6. PubMed ID: 9244643
[TBL] [Abstract][Full Text] [Related]
5. Peripheral neural mechanism of hypertension in rat models--peripheral sympathetic neurotransmission in hypertension.
Masuyama Y; Tsuda K; Kuchii M; Nishio I
J Hypertens Suppl; 1986 Oct; 4(3):S189-92. PubMed ID: 2431119
[TBL] [Abstract][Full Text] [Related]
6. Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure.
Jackson EK; Dubinion JH; Mi Z
Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):29-34. PubMed ID: 18047624
[TBL] [Abstract][Full Text] [Related]
7. GABAB-ergic stimulation in hypothalamic pressor area induces larger sympathetic and cardiovascular depression in spontaneously hypertensive rats.
Takenaka K; Sasaki S; Uchida A; Fujita H; Nakamura K; Ichida T; Itoh H; Nakata T; Takeda K; Nakagawa M
Am J Hypertens; 1996 Oct; 9(10 Pt 1):964-72. PubMed ID: 8896648
[TBL] [Abstract][Full Text] [Related]
8. Flavodilol: a new antihypertensive agent.
Kinsolving CR; Watkins BE; Borrelli AR; Kaiser FC; Wu ES
J Cardiovasc Pharmacol; 1989 Jul; 14(1):127-41. PubMed ID: 2475704
[TBL] [Abstract][Full Text] [Related]
9. Further characterization of the cardiovascular effects of the dopamine beta-hydroxylase inhibitor SK&F 102698 in conscious hypertensive rats.
Ohlstein EH; Kruse LI; Ezekiel M; Willette RN
J Pharmacol Exp Ther; 1988 Oct; 247(1):186-95. PubMed ID: 3050029
[TBL] [Abstract][Full Text] [Related]
10. Effect of clonidine on tyrosine hydroxylase activity in the adrenal medulla and brain of spontaneously hypertensive rats.
Moura E; Afonso J; Serrão MP; Vieira-Coelho MA
Basic Clin Pharmacol Toxicol; 2009 Feb; 104(2):113-21. PubMed ID: 19067675
[TBL] [Abstract][Full Text] [Related]
11. Role of renal sympathetic nerves in regulating renovascular responses to angiotensin II in spontaneously hypertensive rats.
Dubinion JH; Mi Z; Jackson EK
J Pharmacol Exp Ther; 2006 Jun; 317(3):1330-6. PubMed ID: 16537795
[TBL] [Abstract][Full Text] [Related]
12. Alpha-Monofluoromethyldopa (MFMD) in combination with L-DOPA Effects on tissue catecholamines and blood pressure in rats.
Johansson P; Henning M
Naunyn Schmiedebergs Arch Pharmacol; 1982 Oct; 321(1):28-31. PubMed ID: 7144925
[TBL] [Abstract][Full Text] [Related]
13. Role of the sympathetic nervous system in the maintenance of hypertension in rats harboring pheochromocytoma.
Prokocimer PG; Maze M; Hoffman BB
J Pharmacol Exp Ther; 1987 Jun; 241(3):870-4. PubMed ID: 3598906
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of peripheral sympathetic function by alpha-monofluoromethyldopa, an irreversible inhibitor of aromatic amino acid decarboxylase [proceedings].
Fozard JR; Palfreyman MG; Spedding M; Wagner J; Woodward JK
Br J Pharmacol; 1979 Nov; 67(3):461P. PubMed ID: 497578
[No Abstract] [Full Text] [Related]
15. Leukotriene D4: cardiovascular and sympathetic effects in spontaneously hypertensive rats (SHR) and Wistar-Kyoto (WKY) rats.
Zukowska-Grojec Z; Bayorh MA; Kopin IJ; Feuerstein G
J Pharmacol Exp Ther; 1982 Oct; 223(1):183-9. PubMed ID: 6896889
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Ang II and renal sympathetic nerve influence dopamine-and isoprenaline-induced renal haemodynamic changes in normal Wistar-Kyoto and spontaneously hypertensive rats.
Abdulla MH; Sattar MA; Abdullah NA; Hazim AI; Anand Swarup KR; Rathore HA; Khan MA; Johns EJ
Auton Autacoid Pharmacol; 2008 Oct; 28(4):95-101. PubMed ID: 18778332
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological, hemodynamic and autonomic nervous system mechanisms responsible for the blood pressure and heart rate lowering effects of pergolide in rats.
Cavero I; Lefevre-Borg F; Lhoste F; Sabatier C; Richer C; Giudicelli JF
J Pharmacol Exp Ther; 1984 Mar; 228(3):779-91. PubMed ID: 6707926
[TBL] [Abstract][Full Text] [Related]
18. Leukotriene D4 inhibits cardiovascular responses to sympathetic stimulation, angiotensin and vasopressin in the pithed spontaneously hypertensive rats.
Bayorh MH; Zukowska-Grojec Z; Kopin IJ; Feuerstein G
J Pharmacol Exp Ther; 1984 Oct; 231(1):85-90. PubMed ID: 6491978
[TBL] [Abstract][Full Text] [Related]
19. Norepinephrine release and vascular response elicited by nerve stimulation in rats with chronic neurogenic hypertension.
Granata AR; Enero MA; Krieger EM; Langer SZ
J Pharmacol Exp Ther; 1983 Oct; 227(1):187-93. PubMed ID: 6312017
[TBL] [Abstract][Full Text] [Related]
20. Metabolic mapping in the sympathetic ganglia and brain of the spontaneously hypertensive rat.
Kadekaro M; Savaki HE; Kutyna FA; Davidsen L; Sokoloff L
J Cereb Blood Flow Metab; 1983 Dec; 3(4):460-7. PubMed ID: 6630315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
